Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine-n-butylbromide for CRBD in Cesarean Delivery
NCT03513250Completed
- Sponsor
- Cairo University
- Start
- May 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyoscine butylbromide in cystitis (2 arms), sponsored by Cairo University. Primary endpoint: Catheter Related Bladder Discomfort. Started May 2018; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT03513250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513250.